Home > Open-label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-moderate Alzheimer’s Disease
Open-label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-moderate Alzheimer’s Disease
Manuscript Number:
18-0595R1
Author(s):
Alireza Atri, Clive G. Ballard, Neli Boneva, Jeffrey Cummings, Lutz Frölich, Marie A. Geist, José-Luis Molinuevo, Lars L. Raket, Pierre N. Tariot